Secondary analysis of a randomised trial of naldemedine (77 patients starting opioids for cancer pain) set the minimal important change for the PAC-QOL questionnaire at 0.14 to 0.41 for the overall scale and 0.20 to 1.80 for the satisfaction subscale.
Secondary analysisn = 77
Higashibata et al. Establishing the minimal important change for Patient Assessment of Constipation Quality of Life questionnaire for the prevention of opioid-induced constipation in patients with cancer pain